close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

Strona główna・Stock List・Seres Therapeutics Inc
Search

Seres Therapeutics Inc

Closed

SectorHealthcare

14.85 -1.98

Buy

Price update 19 gru 2025, 20:57 UTC

BuySell

Overview

Share price change

24h

Current

Min

14.31

Max

14.91

Key metrics

By Trading Economics

Income

28M

8.2M

Sales

351K

351K

P/E

Sector Avg

18.068

76.798

EPS

0.94

Profit margin

2,337.322

Employees

103

EBITDA

28M

9.3M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+46.86% upside

Market Stats

By TradingEconomics

Market Cap

10M

144M

Previous open

16.83

Previous close

14.85

News Sentiment

By Acuity

28%

72%

56 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

N/A / 9.31 Support & Resistance

Seres Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

19 gru 2025, 17:29 UTC

Acquisitions, Mergers, Takeovers

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

DJ

Read

19 gru 2025, 16:47 UTC

Major Market Movers

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

DJ

Read

19 gru 2025, 16:10 UTC

Acquisitions, Mergers, Takeovers

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

DJ

Read

21 gru 2025, 23:51 UTC

Market Talk

Oil Rises Amid Growing U.S.-Venezuela Tensions -- Market Talk

DJ

Read

21 gru 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

21 gru 2025, 23:45 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

DJ

Read

21 gru 2025, 23:35 UTC

Market Talk

Gold Edges Higher Amid Geopolitical Tensions -- Market Talk

DJ

Read

19 gru 2025, 22:33 UTC

Earnings

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

DJ

Read

19 gru 2025, 22:19 UTC

Earnings

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

DJ

Read

19 gru 2025, 21:48 UTC

Acquisitions, Mergers, Takeovers

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

DJ

Read

19 gru 2025, 21:44 UTC

Earnings

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

DJ

Read

19 gru 2025, 21:38 UTC

Earnings

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

DJ

Read

19 gru 2025, 21:00 UTC

Market Talk

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

DJ

Read

19 gru 2025, 20:23 UTC

Market Talk

Oil Futures End Down Week on Up Note -- Market Talk

DJ

Read

19 gru 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

DJ

Read

19 gru 2025, 18:38 UTC

Market Talk

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

DJ

Read

19 gru 2025, 18:00 UTC

Market Talk
Earnings

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

DJ

Read

19 gru 2025, 17:41 UTC

Earnings

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

DJ

Read

19 gru 2025, 17:24 UTC

Market Talk
Earnings

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

DJ

Read

19 gru 2025, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

19 gru 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

DJ

Read

19 gru 2025, 16:29 UTC

Earnings

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

DJ

Read

19 gru 2025, 16:20 UTC

Acquisitions, Mergers, Takeovers

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

DJ

Read

19 gru 2025, 16:19 UTC

Acquisitions, Mergers, Takeovers

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

DJ

Read

19 gru 2025, 16:18 UTC

Acquisitions, Mergers, Takeovers

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

DJ

Read

19 gru 2025, 16:16 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

19 gru 2025, 16:16 UTC

Market Talk

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

DJ

Read

19 gru 2025, 16:05 UTC

Acquisitions, Mergers, Takeovers

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

DJ

Read

19 gru 2025, 16:04 UTC

Acquisitions, Mergers, Takeovers

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

DJ

Read

19 gru 2025, 15:37 UTC

Market Talk

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

DJ

Read

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

46.86% upside

12 Months Forecast

Average 22 USD  46.86%

High 22 USD

Low 22 USD

Based on 2 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Seres Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Sentiment

By Acuity

56 / 374 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,072.27

↑ +1.4%

JNJ

Johnson and Johnson

206

↓-1.09%

ABBV

AbbVie Inc

227.14

↑ +1.9%

UNH

UnitedHealth Group Inc

327.43

↓-0.31%

AZN

AstraZeneca PLC ADR

91.35

↑ +0.79%
help-icon Live chat